Docetaxel in Patients with Anthracycline-Resistant Advanced Breast Cancer

Objective: To better determine docetaxel activity in patients with well-defined anthracycline-resistant breast cancer. Methods: From October 1996, we carried out a phase II trial in 69 heavily pretreated patients with advanced breast cancer with docetaxel 100 mg/m 2 by a 1-hour infusion on day 1, wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology 2001-01, Vol.60 (1), p.60-65
Hauptverfasser:	Vici, Patrizia, Belli, Franca, Di Lauro, Luigi, Amodio, Antonella, Conti, Francesca, Foggi, Paolo, Gionfra, Tommaso, Morelli, Maria Francesca, Botti, Claudio, Ferraironi, Alessandro, Lopez, Massimo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibiotics, Antineoplastic - therapeutic use Antineoplastic agents Antineoplastic Agents, Phytogenic - administration & dosage Antineoplastic Agents, Phytogenic - adverse effects Antineoplastic Agents, Phytogenic - therapeutic use Biological and medical sciences Breast Neoplasms - drug therapy Breast Neoplasms - pathology Chemotherapy Clinical Study Drug Administration Schedule Drug Resistance, Neoplasm Female Granulocyte Colony-Stimulating Factor - therapeutic use Gynecology. Andrology. Obstetrics Humans Infusions, Intravenous Mammary gland diseases Medical sciences Middle Aged Neutropenia - chemically induced Neutropenia - drug therapy Paclitaxel - administration & dosage Paclitaxel - adverse effects Paclitaxel - analogs & derivatives Paclitaxel - therapeutic use Pharmacology. Drug treatments Survival Analysis Taxoids Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!